Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Johnson, Stanley
DOB:	05-MAR-1941 (Age: 85)
Gender:	male
Address:	289 Smith garden TN1 Terencebury (United Kingdom)
ID:	7188-531997-1 (ECI)

Report
Date:	22-AUG-2020

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Evelina Children's Hospital SE1 7 London (United Kingdom)

Specimen
Collected:	22-AUG-2020

Hematology

Test	22-AUG-2020	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	9.9	4.5 - 11.0	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.1 L	4.3 - 5.7	10*6/uL
Hemoglobin [Mass/volume] in Blood	15.1	13.5 - 17.5	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	45.4	36 - 50	%
MCV [Entitic mean volume] in Red Blood Cells by Automated count	83.0	80 - 100	fL
MCH [Entitic mass] by Automated count	29.4	27 - 33	pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count	33.5	32 - 36	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	41.5	36 - 46	fL
Platelets [#/volume] in Blood by Automated count	266.9	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	494.1 H	9.9 - 17.2	fL
Platelet [Entitic mean volume] in Blood by Automated count	9.8	6.4 - 11.2	fL

Chemistry

Test	22-AUG-2020	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	5.6	4.8 - 5.9	%
Glucose [Mass/volume] in Blood	178.2 H	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	14.4	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.9	0.7 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.6	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	141.1	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.1	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	106.1	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	28.0	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	255.8 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	273.4 H	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	167.1 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	34.0 L	40 - 60	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	3.8	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant hyperglycemia with normal HbA1c, suggesting possible acute glucose elevation. There is marked dyslipidemia (high total cholesterol, LDL, triglycerides, and low HDL), increasing cardiovascular risk. Mild erythrocytopenia is present, but other hematologic and renal parameters are within normal limits. Recommend further evaluation of glucose control, lipid management, and assessment for underlying causes of erythrocytopenia.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows significant hyperglycemia with normal HbA1c, suggesting possible acute glucose elevation. There is marked dyslipidemia (high total cholesterol, LDL, triglycerides, and low HDL), increasing cardiovascular risk. Mild erythrocytopenia is present, but other hematologic and renal parameters are within normal limits. Recommend further evaluation of glucose control, lipid management, and assessment for underlying causes of erythrocytopenia.